Near the dawn of the 20th century, human life expectancy began to jump significantly thanks to new scientific insights into matters like handwashing, vaccines, and food safety. In recent decades, though, expected life spans have plateaued or even declined. Coinbase CEO Brian Armstrong believes this situation can be reversed, and says a health startup he cofounded is making faster than expected progress repairing cells in order to create longer and better lives.
On Tuesday, that startup—NewLimit—raised a $130 million Series B round led by venture capital giant Kleiner Perkins with contributions from new and existing investors including Khosla Ventures and Founders Fund.
